[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis

被引:0
作者
Serezal, I. Gallais [1 ,2 ]
Ferkal, S. [3 ]
Lerman, L. [4 ]
Mule, S. [5 ]
Funalot, B. [2 ]
Wolkenstein, P. [3 ,6 ]
机构
[1] CHU Besancon, Serv Dermatol, Besancon, France
[2] Hop Henri Mondor, AP HP, Dept Genet, Creteil, France
[3] Hop Henri Mondor, AP HP, Ctr Reference Neurofibromatoses, Ctr Invest Clin 006,INSERM, Creteil, France
[4] Hop Henri Mondor, AP HP, Serv Med Nucl, Creteil, France
[5] Hop Henri Mondor, AP HP, Serv Radiol, Creteil, France
[6] Hop Henri Mondor, AP HP, Serv Dermatol, Creteil, France
关键词
Schwannomatosis; Diagnosis; ([18F])FDG-PET; MRI;
D O I
10.1186/s13023-021-01680-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Schwannomatosis is a rare autosomal dominant genetic syndrome characterized by the presence of multiple schwannomas. The main symptom is neurogenic pain. The diagnosis requires the presence of several schwannomas and whole-body ([18F])FDG-PET/MRI might help detect extra schwannomas in patients when the diagnosis is uncertain. Among the 25 patients treated for Schwannomatosis in our tertiary center, three men and two women had had a ([18F])FDG-PET/MRI performed, and the number of schwannomas detected by ([18F])FDG-PET/MRI outnumbered the number of schwannomas suspected during the clinical examination. The majority of schwannomas exhibited a radiolabeling (median of 66.7%, range 28-93%). Our findings show that ([18F])FDG-PET/MRI could prove useful when suspecting schwannomatosis to accelerate diagnosis and offer optimal care to patients.
引用
收藏
页数:5
相关论文
共 10 条
[1]  
Adam M, 1993, GENEREVIEWS, P1993
[2]   Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis [J].
Ahlawat, Shivani ;
Baig, Asad ;
Blakeley, Jaishri O. ;
Jacobs, Michael A. ;
Fayad, Laura M. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 44 (04) :794-803
[3]   Schwannomatosis/neurofibromatosis type 2 associated visualized on FDG-PET/CT [J].
Beylergil, V. ;
Haque, S. ;
Carver, A. ;
Bilsky, M. H. ;
Carrasquillo, J. A. .
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2013, 32 (04) :275-276
[4]   Whole-body imaging in schwannomatosis [J].
Chhabra, Avneesh ;
Blakely, Jaishri .
NEUROLOGY, 2011, 76 (23) :2035-2035
[5]  
Cho DH., 2018, BMJ CASE REP, V2018, P1
[6]   MRI IN ACOUSTIC NEUROMA - A REVIEW OF 35 PATIENTS [J].
CURATI, WL ;
GRAIF, M ;
KINGSLEY, DPE ;
KING, T ;
SCHOLTZ, CL ;
STEINER, RE .
NEURORADIOLOGY, 1986, 28 (03) :208-214
[7]   Utility of positron emission tomography in schwannomatosis [J].
Lieber, Bryan ;
Han, ByoungJun ;
Allen, Jeffrey ;
Fatterpekar, Girish ;
Agarvval, Nitin ;
Kazemi, Noojan ;
Zagzag, David .
JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 30 :138-140
[8]   Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients [J].
Merker, Vanessa L. ;
Esparza, Sonia ;
Smith, Miriam J. ;
Stemmer-Rachamimov, Anat ;
Plotkin, Scott R. .
ONCOLOGIST, 2012, 17 (10) :1317-1322
[9]   FDG PET/CT of Intercostal Schwannoma [J].
Wang, Si-Yun ;
Luo, Dong-Lan ;
Chen, Gang ;
Liu, En-Tao ;
Wang, Shu-Xia .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (06) :E310-E312
[10]   Schwannomatosis: A clinical entity distinct from neurofibromatosis type 2 [J].
Wolkenstein, P ;
Benchikhi, H ;
Zeller, J ;
Wechsler, J ;
Revuz, J .
DERMATOLOGY, 1997, 195 (03) :228-231